📍 1 Triton Square, London NW1 3BF
What could you discover if you could see biology in greater depth, detail and context?
In partnership with Thermo Fisher Scientific, join us for an evening exploring how advances in spectral flow cytometry and spatial imaging are opening new ways to understand cells, tissues and complex biological systems , and creating new possibilities across biological research and drug discovery.
Hear from leading researchers and innovators, including Relation, alongside Thermo Fisher Scientific experts, as they share real-world applications, emerging approaches and the biological questions these technologies are helping to answer.
Go beyond the presentations and experience the technology first-hand through live demonstrations, meet the teams behind the innovations, and explore how spectral and spatial approaches can reveal insights that were previously difficult to see.
Whether you are working in academic research, biotech, pharma, or drug discovery, or simply exploring what these technologies could bring to your research, this is an opportunity to discover new possibilities, exchange ideas and connect with London's life science community.
Powered by Advanced Research + Invention Agency
In partnership with Thermo Fisher
Our Thursday Gatherings are for you to make serendipitous connections and make things happen!
There will be meaningful networking opportunities throughout the night, accompanied by a selection of refreshments and activities:
Fun Zone
Get to know your fellow change-makers in a fun, interactive, and exciting way!
Take a quick break from changing the world and recharge by pinning your hometown on our giant map.
Conversation Corner
Looking to connect beyond the name tags?
Drop into our relaxed Conversation Corner, a cosy space where founders, ecosystem builders, and global thinkers come together to share stories, swap lessons, and innovate. Grab a drink, pull up a chair, and jump into the discussion.
Thermo Fisher Scientific is advancing spectral and spatial biology with next-generation technologies, helping turn complex biological data into deeper, more meaningful discoveries.
Join us to interact with some of thier incredible equipment.
Drop by the Thermo Fisher Clinic throughout the evening to meet the team, discover what they do, and explore the technologies helping researchers, healthcare professionals and innovators push science forward.
Introductions from Venture Café London and Thermo Fisher Scientific
Seeing More in Every Sample: Spatial & Spectral Imaging from Biological Discovery to Clinical Insight
Hear from our experts about how spectral and spatial technology advances life science and clinical research programmes. By revealing cellular diversity, molecular signatures, and spatial interactions with greater depth, these technologies can accelerate the discovery of disease mechanisms and biomarkers. These insights can help bridge discovery and clinical research, supporting patient stratification, therapeutic development, and the advancement of precision medicine.
Ben Arnold is a sales manager across Europe with 12 years experience covering imaging and spatial solutions at Thermo Fisher Scientific. Before his sales career he completed his degree in Genetics at the University of Aberdeen subsequently moving into antibody engineering and cancer therapeutics postions within local biotech companies and then working with Wyeth and Pfizer to identify lead candidates from its antibody library.
Ashley Box is a Director of Corporate Accounts and Global Enterprise Relationship Lead (GERL) at Thermo Fisher Scientific, bringing more than 30 years of experience with the company.
Throughout his career, Ashley has developed extensive experience across the drug development journey, from drug discovery and clinical trials through to large-scale commercial production. In his current role, he is responsible for building and strengthening strategic relationships with global customers, aligning mutual objectives and identifying opportunities to create additional value across Thermo Fisher Scientific’s broad portfolio of products, services and capabilities.
Ashley works across businesses, functions and geographies, bringing together cross-divisional teams to improve customer experience, share best practices and deliver coordinated solutions. He also provides leadership for joint strategic projects and initiatives, helping customers access the breadth of Thermo Fisher Scientific’s capabilities through a single, connected enterprise relationship.
Adyary Fallarero is a Sr. Manager within Product Management at Thermo Fisher and an Adjunct Professor in Pharmaceutical Biology at the Faculty of Pharmacy, University of Helsinki, Finland. She earned PhD in Biochemistry
from the University of Havana, Cuba and a Master in International Business Management (MBA) from the Tampere University of Applied Sciences.
During her more than 10 years of academic career, she published over 80 peer-reviewed publications, co-authored over 10 patents, and was awarded multiple grants to lead research programs focused on early drug discovery of
anti-biofilms. In 2018, she received the prestigious Oskar Öflund’s Foundation Grand Prize, for her pioneering contributions to the development of the field of bacterial biofilms in Finland.
She joined Thermo Fisher Scientific in 2016 to work on cell analysis instrumentation, gaining significant expertise in new product development and product management. Since 2021, she has been responsible for new product
introductions, portfolio management and commercial enablement of cell and tissue imaging systems.
Max Kirtland is a Principal Scientist at GSK within the Cellular Biomarkers group. After completing a PhD at Imperial College London, he moved into translational science and drug discovery, specialising in immunology and high-parameter flow cytometry. His work focuses on developing and applying cellular profiling assays to support biomarker discovery, clinical immunophenotyping, and therapeutic development.
Andrea Predonzani is the EMEA Application Territory Specialist at Thermo Fisher Scientific. With a degree in Medical Biotechnology and a PhD in Molecular Genetics and Biotechnology, Andrea brings extensive academic and industry experience. Since joining Thermo Fisher Scientific in 2015, firstly as Field Application scientist and since 2018 in his actual role, he has supported the introduction and the adoption of innovative instruments, provided scientific guidance, and collaborated with customers, internal partners, and Research and Development teams to bring forward future solution development in the cell analysis field, mainly on flow and imaging instrument portfolio.
Amaia is Senior Director of Molecular Profiling and Sequencing at Relation, a drug discovery techbio. She holds a degree in Biology and Biochemistry, and a PhD in Molecular Biology from the University of Navarra.
She began her career in oncohaematological research, focusing on drug discovery and conducting both in vitro and in vivo screening of proprietary compounds targeting epigenetic mechanisms. Over the past nine years, she has specialised in single-cell, spatial transcriptomics, and sequencing technologies to advance biological and disease understanding across multiple cancer indications and rare diseases. She has also contributed to large-scale initiatives such as the B-cell Atlas project, helping to deepen insights into immune system biology.
Since joining Relation in 2023, her role has involved operating at the intersection of internal clinical study data, machine learning platform development, and external pharmaceutical collaborations, focusing on the identification and prioritisation of novel targets across osteoporosis and other disease areas. Her work focuses on translating these insights into therapeutic opportunities with the potential to transform patients’ lives across multiple indications.
📍 1 Triton Square, London NW1 3BF
What could you discover if you could see biology in greater depth, detail and context?
In partnership with Thermo Fisher Scientific, join us for an evening exploring how advances in spectral flow cytometry and spatial imaging are opening new ways to understand cells, tissues and complex biological systems , and creating new possibilities across biological research and drug discovery.
Hear from leading researchers and innovators, including Relation, alongside Thermo Fisher Scientific experts, as they share real-world applications, emerging approaches and the biological questions these technologies are helping to answer.
Go beyond the presentations and experience the technology first-hand through live demonstrations, meet the teams behind the innovations, and explore how spectral and spatial approaches can reveal insights that were previously difficult to see.
Whether you are working in academic research, biotech, pharma, or drug discovery, or simply exploring what these technologies could bring to your research, this is an opportunity to discover new possibilities, exchange ideas and connect with London's life science community.
Powered by Advanced Research + Invention Agency
In partnership with Thermo Fisher
Our Thursday Gatherings are for you to make serendipitous connections and make things happen!
There will be meaningful networking opportunities throughout the night, accompanied by a selection of refreshments and activities:
Fun Zone
Get to know your fellow change-makers in a fun, interactive, and exciting way!
Take a quick break from changing the world and recharge by pinning your hometown on our giant map.
Conversation Corner
Looking to connect beyond the name tags?
Drop into our relaxed Conversation Corner, a cosy space where founders, ecosystem builders, and global thinkers come together to share stories, swap lessons, and innovate. Grab a drink, pull up a chair, and jump into the discussion.
Thermo Fisher Scientific is advancing spectral and spatial biology with next-generation technologies, helping turn complex biological data into deeper, more meaningful discoveries.
Join us to interact with some of thier incredible equipment.
Drop by the Thermo Fisher Clinic throughout the evening to meet the team, discover what they do, and explore the technologies helping researchers, healthcare professionals and innovators push science forward.
Introductions from Venture Café London and Thermo Fisher Scientific
Seeing More in Every Sample: Spatial & Spectral Imaging from Biological Discovery to Clinical Insight
Hear from our experts about how spectral and spatial technology advances life science and clinical research programmes. By revealing cellular diversity, molecular signatures, and spatial interactions with greater depth, these technologies can accelerate the discovery of disease mechanisms and biomarkers. These insights can help bridge discovery and clinical research, supporting patient stratification, therapeutic development, and the advancement of precision medicine.
Ben Arnold is a sales manager across Europe with 12 years experience covering imaging and spatial solutions at Thermo Fisher Scientific. Before his sales career he completed his degree in Genetics at the University of Aberdeen subsequently moving into antibody engineering and cancer therapeutics postions within local biotech companies and then working with Wyeth and Pfizer to identify lead candidates from its antibody library.
Ashley Box is a Director of Corporate Accounts and Global Enterprise Relationship Lead (GERL) at Thermo Fisher Scientific, bringing more than 30 years of experience with the company.
Throughout his career, Ashley has developed extensive experience across the drug development journey, from drug discovery and clinical trials through to large-scale commercial production. In his current role, he is responsible for building and strengthening strategic relationships with global customers, aligning mutual objectives and identifying opportunities to create additional value across Thermo Fisher Scientific’s broad portfolio of products, services and capabilities.
Ashley works across businesses, functions and geographies, bringing together cross-divisional teams to improve customer experience, share best practices and deliver coordinated solutions. He also provides leadership for joint strategic projects and initiatives, helping customers access the breadth of Thermo Fisher Scientific’s capabilities through a single, connected enterprise relationship.
Adyary Fallarero is a Sr. Manager within Product Management at Thermo Fisher and an Adjunct Professor in Pharmaceutical Biology at the Faculty of Pharmacy, University of Helsinki, Finland. She earned PhD in Biochemistry
from the University of Havana, Cuba and a Master in International Business Management (MBA) from the Tampere University of Applied Sciences.
During her more than 10 years of academic career, she published over 80 peer-reviewed publications, co-authored over 10 patents, and was awarded multiple grants to lead research programs focused on early drug discovery of
anti-biofilms. In 2018, she received the prestigious Oskar Öflund’s Foundation Grand Prize, for her pioneering contributions to the development of the field of bacterial biofilms in Finland.
She joined Thermo Fisher Scientific in 2016 to work on cell analysis instrumentation, gaining significant expertise in new product development and product management. Since 2021, she has been responsible for new product
introductions, portfolio management and commercial enablement of cell and tissue imaging systems.
Max Kirtland is a Principal Scientist at GSK within the Cellular Biomarkers group. After completing a PhD at Imperial College London, he moved into translational science and drug discovery, specialising in immunology and high-parameter flow cytometry. His work focuses on developing and applying cellular profiling assays to support biomarker discovery, clinical immunophenotyping, and therapeutic development.
Andrea Predonzani is the EMEA Application Territory Specialist at Thermo Fisher Scientific. With a degree in Medical Biotechnology and a PhD in Molecular Genetics and Biotechnology, Andrea brings extensive academic and industry experience. Since joining Thermo Fisher Scientific in 2015, firstly as Field Application scientist and since 2018 in his actual role, he has supported the introduction and the adoption of innovative instruments, provided scientific guidance, and collaborated with customers, internal partners, and Research and Development teams to bring forward future solution development in the cell analysis field, mainly on flow and imaging instrument portfolio.
Amaia is Senior Director of Molecular Profiling and Sequencing at Relation, a drug discovery techbio. She holds a degree in Biology and Biochemistry, and a PhD in Molecular Biology from the University of Navarra.
She began her career in oncohaematological research, focusing on drug discovery and conducting both in vitro and in vivo screening of proprietary compounds targeting epigenetic mechanisms. Over the past nine years, she has specialised in single-cell, spatial transcriptomics, and sequencing technologies to advance biological and disease understanding across multiple cancer indications and rare diseases. She has also contributed to large-scale initiatives such as the B-cell Atlas project, helping to deepen insights into immune system biology.
Since joining Relation in 2023, her role has involved operating at the intersection of internal clinical study data, machine learning platform development, and external pharmaceutical collaborations, focusing on the identification and prioritisation of novel targets across osteoporosis and other disease areas. Her work focuses on translating these insights into therapeutic opportunities with the potential to transform patients’ lives across multiple indications.